| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.07 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.07 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |